Business Context and Reporting Period
Company: Church & Dwight Co., Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2008
Business Overview: The Company develops, manufactures, and markets household, personal care, and specialty products under brands such as ARM & HAMMER and TROJAN. Operations are divided into three segments: Consumer Domestic (71% of sales), Consumer International (17%), and Specialty Products (12%).
Key Financial Metrics
| Metric | 2008 | 2007 |
|---|---|---|
| Net Sales | $2,422.4 million | $2,220.9 million |
| Gross Profit | $971.7 million | $867.9 million |
| Gross Margin | 40.1% | 39.1% |
| Income from Operations | $340.3 million | $305.0 million |
| Net Income | $195.2 million | $169.0 million |
| Diluted EPS | $2.78 | $2.46 |
| Total Debt | $856.1 million | $856.0 million |
| Cash and Equivalents | $198.0 million | $249.8 million |
| Operating Cash Flow | $336.2 million | $248.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.1% to $2,422.4 million, driven by the Orajel Acquisition (approx. 3% of increase), higher unit volumes, and price increases. This was partially offset by the divestiture of the Brotherton subsidiary in the UK and the Spanish subsidiary.
- Profitability: Operating income rose 11.6% to $340.3 million. Gross margin improved by 100 basis points due to price increases, cost reduction programs, and the shift to concentrated liquid laundry detergent, offset by higher commodity costs and a $4.5 million loss on diesel fuel hedges.
- Acquisitions and Divestitures:
- Orajel Acquisition: Purchased Del Pharmaceuticals' OTC business for $383.4 million in July 2008, funded by $250 million in new debt and cash.
- Divestitures: Sold the UK subsidiary (Brotherton) for a $3.0 million pretax gain and the Spanish subsidiary for a $3.5 million pretax charge.
- Debt Structure: Total debt remained flat at $856.1 million. The Company redeemed $99.9 million of convertible debentures (converted to stock) and increased term loans to fund the Orajel acquisition.
Guidance, Outlook, and Risks
- Capital Projects: Construction began on a new integrated laundry detergent plant in York County, Pennsylvania, scheduled for completion in late 2009. This will coincide with the closure of the North Brunswick, NJ facility, involving approximately 300 employee severances and $150 million in total capital expenditures.
- Economic Risks: Management notes uncertainty in global economic conditions affecting consumer demand. The Company is monitoring customer financial strength and has modified credit limits where necessary. There is a risk of increased private label competition as consumers reduce discretionary spending.
- Commodity and Hedging: Raw material costs (soda ash, surfactants, diesel) remained high. The Company recorded a $4.5 million loss in 2008 due to declining diesel prices impacting its hedge contracts. Future declines in diesel prices could result in additional charges in 2009.
- Regulatory: Ongoing FDA review of N-9 spermicide in Trojan condoms; potential labeling changes could impact sales. Litigation against Abbott Laboratories regarding pregnancy test kits resulted in a $29.2 million award (pending post-trial motions).
Investor Verification Checklist
- York County Plant Progress: Verify the timeline and cost adherence for the new $150 million facility and the associated shutdown costs of the North Brunswick plant.
- Diesel Hedge Impact: Monitor 2009 financial statements for further mark-to-market losses on diesel fuel hedges if fuel prices continue to decline.
- Orajel Integration: Assess the revenue contribution and margin performance of the newly acquired Orajel brand in the Consumer Domestic segment.
- Customer Concentration: Confirm continued stability of sales to Wal-Mart, which accounted for 22% of total net sales in 2008.
- Abbott Litigation: Track the status of the post-trial motions regarding the $29.2 million patent infringement award.